Canaural ausu pilieni, suspensija suņiem un kaķiem
Canaural ausu pilieni, suspensija suņiem un kaķiem
Authorised
- Diethanolamine fusidate
- Framycetin sulfate
- Nystatin
- Prednisolone
Product identification
Medicine name:
Canaural ausu pilieni, suspensija suņiem un kaķiem
Active substance:
- Diethanolamine fusidate
- Framycetin sulfate
- Nystatin
- Prednisolone
Target species:
-
Cat
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Diethanolamine fusidate5.00/milligram(s)1.10millilitre(s)
-
Framycetin sulfate5.00/milligram(s)1.10millilitre(s)
-
Nystatin100000.00/international unit(s)1.10millilitre(s)
-
Prednisolone2.50/milligram(s)1.10millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
- Dales Pharmaceuticals Limited
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/NRP/96/0293
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 5/04/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 5/04/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 5/04/2024